---
title: "NEXGEL ANNOUNCES LEADERSHIP TRANSITION AND STRATEGIC REVIEW INITIATIVE"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296532766.md"
description: "On August 20, 2026, NEXGEL, Inc. (NASDAQ: “NXGL”) based in Langhorne, Pennsylvania, unveiled several key measures aimed at bolstering operational performance, increasing liquidity, and maximizing shareholder value. The Company, also known as \"NEXGEL,\" introduced new leadership, governance, and strategic plans to achieve these goals effectively."
datetime: "2026-08-20T20:06:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296532766.md)
  - [en](https://longbridge.com/en/news/296532766.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296532766.md)
generator: "portal-rs"
---

# NEXGEL ANNOUNCES LEADERSHIP TRANSITION AND STRATEGIC REVIEW INITIATIVE

On August 20, 2026, NEXGEL, Inc. (NASDAQ: “NXGL”) based in Langhorne, Pennsylvania, unveiled several key measures aimed at bolstering operational performance, increasing liquidity, and maximizing shareholder value. The Company, also known as "NEXGEL," introduced new leadership, governance, and strategic plans to achieve these goals effectively.

### Related Stocks

- [NXGL.US](https://longbridge.com/en/quote/NXGL.US.md)
- [NXGLW.US](https://longbridge.com/en/quote/NXGLW.US.md)

## Related News & Research

- [NXGL: Q2 revenue reached $3.69M with a $2.87M net loss; integration and expansion efforts continue](https://longbridge.com/en/news/296106108.md)
- [Nexgel’s Celularity Deal: Execution, Integration, and Profitability Risks from $13.3 Million Biomaterials Acquisition](https://longbridge.com/en/news/296183101.md)
- [10:31 ETLiver Cirrhosis Market to Expand Significantly Through 2036, Driven by Emerging Therapies and Increasing Disease Burden | DelveInsight](https://longbridge.com/en/news/296802956.md)
- [$1000 Invested In Veeco Instruments 5 Years Ago Would Be Worth This Much Today](https://longbridge.com/en/news/296657245.md)
- [Top 3 Risk Off Stocks That May Collapse In August](https://longbridge.com/en/news/296792948.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**